The organic pharmaceutical excipients market has seen considerable growth due to a variety of factors.
•There has been a notable upsurge in the size of the organic pharmaceutical excipients market of late. The market is predicted to increase from $11.25 billion in 2024 to $12.33 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.6%.
Factors contributing to the growth during the historic period include a rise in demand for drug formulations, patient assimilation and conformity, adherence to quality and safety norms, inventive strategies in drug delivery, and the necessity for regulatory compliance.
The organic pharmaceutical excipients market is expected to maintain its strong growth trajectory in upcoming years.
• The market for organic pharmaceutical excipients is slated to witness robust growth in the subsequent years, escalating to "$17.59 billion by 2029 at a 9.3% compound annual growth rate.
The predicted market growth during the forecast period is due to the increase of biopharmaceuticals and biosimilars, the inclination towards natural and sustainable ingredients, emphasis on personalized medicine, the inception of new treatments, and the global surge in pharmaceutical production. The forecast period also anticipates regulatory compliance and quality standards, custom excipient solutions, the inclusion of high-tech advancements, global proliferation of organic excipient suppliers, and research & development efforts towards excipient innovation as the dominant trends.
The organic pharmaceutical excipients market is anticipated to thrive due to the increasing requirement for pharmaceutical drugs. These drugs, commonly known as medications or medicines, are chemical substances utilized to prevent, diagnose, and treat various human diseases and medical conditions. The burgeoning demand for these drugs has amplified the necessity for organic pharmaceutical excipients. These excipients aid in providing suitable and compatible ingredients for organic drug formulations and promoting the drug's physiological absorption. For example, NHS Business Services Authority, a UK-based non-departmental public body of the Department of Health and Social Care, revealed that during 2022-23, 1.18 billion prescription items were distributed in the community in England, marking a 3% climb from 2021-22. Consequently, this uptick in pharmaceutical drug demand is spurring the growth of the organic pharmaceutical excipients market.
The organic pharmaceutical excipients market covered in this report is segmented –
1) By Type: Oleochemicals, Carbohydrates, Petrochemicals, Protein, Other Types
2) By Functions: Binders, Coating Agents, Colorants, Disintegrates, Other Functions
3) By Application: Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications
Subsegments:
1) By Oleochemicals: Fatty Acids, Glycerin, Fatty Alcohols, Surfactants, Esters
2) By Carbohydrates: Starch, Cellulose, Dextrins, Sugars, Pectins
3) By Petrochemicals: Polyethylene Glycol (PEG), Mineral Oils, Synthetic Polymers, Sorbitol, Propylene Glycol
4) By Protein: Gelatin, Albumin, Collagen, Casein, Whey Protein
5) By Other Types: Natural Excipients, Inorganic Excipients, Microcrystalline Cellulose, Others
The trend of incorporating label-friendly excipients in nutritional products is gaining significant traction in the organic pharmaceutical excipients market. Companies in the organic pharmaceutical excipients sector are strategically adopting the use of these excipients in the formulation of nutritional products to maintain their market position. For example, in April 2023, Colorcon, a pharmaceutical excipient provider based in the USA, introduced Nutracore, an innovative array of label-friendly excipients that cater to the specific needs of nutraceutical and supplement providers. These excipients, made from natural and organic materials, are designed to cater to the surging demand for cleaner labeling in the nutritional and dietary supplement sector while ensuring optimum manufacturability and performance. Nutracore excipients allow manufacturers to adhere to consumers' label-friendly requirements without impacting the quality and functionality of their products.
Major companies operating in the organic pharmaceutical excipients market include:
• Roquette Frères SA
• DuPont de Nemours Inc.
• Ashland Inc.
• Badische Anilin- und Sodafabrik
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG
• Merck KGaA
• Colorcon Asia Private Limited
• Rochem International Inc.
• Eastman Chemical Company
• JRS PHARMA GMBH + CO KG
• Cargill Incorporated
• Ingredion Incorporated
• Sensient Technologies Corporation
• Internatio-Müller Chemical Distribution
• Lonza Group Ltd.
• DFE PHARMA INDIA PRIVATE LIMITED.
• Omya AG
• Sigachi Industries Pvt. Ltd.
• Meggle AG
• Associated British Foods plc
• Archer Daniels Midland Company
• Food Machinery & Chemical Corporation
• Innospec Inc.
• Mitsubishi Chemical Corporation
• International Flavors & Fragrances Inc.
North America was the largest region in the global organic pharmaceutical excipients market in 2024. The regions covered in the organic pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa